Cytoplasmic domain and enzymatic activity of ACE2 is not required for PI4KB dependent endocytosis entry of SARS-CoV-2 into host cells
Abstract
The recent COVID-19 pandemic poses a global health emergency. Cellular entry of the causative agent SARS-CoV-2 is mediated by its spike protein interacting with cellular receptor- human angiotensin converting enzyme 2 (ACE2). Here, we used lentivirus based pseudotypes bearing spike protein to demonstrate that entry of SARS-CoV-2 into host cells is dependent on clathrin-mediated endocytosis, and phosphoinositides play essential role during this process. In addition, we showed that the intracellular domain and the catalytic activity of ACE2 is not required for efficient virus entry. These results provide new insights into SARS-CoV-2 cellular entry and present potential targets for drug development.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The proton-activated chloride channel inhibits SARS-CoV-2 spike protein-mediated viral entry through the endosomal pathway.
Nicholas Koylass, Jaiprasath Sachithanandham, … Zhaozhu Qiu·Journal of Cellular PhysiologyPeer-reviewed·Jul 1, 2025
- Niclosamide inhibits SARS-CoV2 entry by blocking internalization through pH-dependent CLIC/GEEC endocytic pathway
C. Prabhakara, R. Godbole, … S. Mayor·bioRxiv·Dec 16, 2020
- SARS-CoV-2 infects cells following viral entry via clathrin-mediated endocytosis
A. Bayati, R. Kumar, … P. S. McPherson·bioRxiv·Jul 13, 2020
- Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus
Federico Cocozza, Ester Piovesana, … Lorena Martin-Jaular·Journal of Extracellular VesiclesPeer-reviewed·Dec 28, 2020
- High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity
- Extracellular vimentin as a target against SARS- CoV-2 host cell invasion
L. Suprewicz, M. Swoger, … A. E. Patteson·bioRxiv·Jan 8, 2021